131I-Caerin 1.1 and 131I-Caerin 1.9 for the treatment of non-small-cell lung cancer

Overview of attention for article published in Frontiers in oncology, August 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 32,328 followers.

New article: 131I-Caerin 1.1 and 131I-Caerin 1.9 for the treatment of non-small-cell lung cancer https://t.co/YVKzbIHV3M #lungcancer #oncology https://t.co/M4TFPTFMij

131I-Caerin 1.1 and 131I-Caerin 1.9 for the treatment of non-small-cell lung cancer: Objective To investigate the effect of the 131I-labeled high-affinity peptides Caerin 1.1 and Caerin 1.9 for the treatment of A549 human NSCLC #oncology… https://t.co/ky…

New research: 131I-Caerin 1.1 and 131I-Caerin 1.9 for the treatment of non-small-cell lung cancer: Objective To investigate the effect of the 131I-labeled high-affinity peptides Caerin 1.1 and Caerin 1.9 for the treatment of A549 human NSCLC… https://t.c…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.